Zhonghua er bi yan hou ke za zhi · 2000
[The outcome of 1268 cases of endoscopic sinus surgery].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Y, Yu D, Xing Z
Аннотация
OBJECTIVE: To evaluate the curative effect of endoscopic sinus surgery (ESS).
METHODS: One thousand two hundred and sixty-eight cases with chronic sinusitis and nasal polyps undergone ESS from 1989 to 1997 were appraised with the standard criteria (Chinese ENT Association, 1997). There were 366 cases(28.9%) in type 1, 646 cases(50.9%) in type 2 and 256 cases(20.2%) in type 3. One thousand two hundred and sixty-two cases underwent ESS under intranasal local anesthesia and sedation; 182 cases underwent submucous resection of nasal septum or septoplasty. Long-term follow-up was performed at 9 to 42 months(mean = 15 months).
RESULTS: The results showed that cure rate was 93.7% for type 1, 81.6% for type 2 and 68.4% for type 3. There was significant difference in cure rate among different types (P < 0.01). Complication of ESS in 1,268 cases occurred in 2.3%.
CONCLUSION: ESS is efficacy and safe in the treatment of nasal polyps and chronic sinusitis. The cure result is directly related to the types of the disease.
METHODS: One thousand two hundred and sixty-eight cases with chronic sinusitis and nasal polyps undergone ESS from 1989 to 1997 were appraised with the standard criteria (Chinese ENT Association, 1997). There were 366 cases(28.9%) in type 1, 646 cases(50.9%) in type 2 and 256 cases(20.2%) in type 3. One thousand two hundred and sixty-two cases underwent ESS under intranasal local anesthesia and sedation; 182 cases underwent submucous resection of nasal septum or septoplasty. Long-term follow-up was performed at 9 to 42 months(mean = 15 months).
RESULTS: The results showed that cure rate was 93.7% for type 1, 81.6% for type 2 and 68.4% for type 3. There was significant difference in cure rate among different types (P < 0.01). Complication of ESS in 1,268 cases occurred in 2.3%.
CONCLUSION: ESS is efficacy and safe in the treatment of nasal polyps and chronic sinusitis. The cure result is directly related to the types of the disease.